FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags
Status: Currently in Shortage
»Date first posted: 10/25/2017
»Therapeutic Categories: Cardiovascular

Expand all

B. Braun Medical Inc. (Revised 11/02/2017)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.8% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5982 (NDC 00264-9598-20) Product on allocation to contracted customers

Dear Customer Letter

Manufacturing interruptions and demand increase
0.4% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5942 (NDC 00264-9594-20) Product on allocation to contracted customers

Dear Customer Letter

Manufacturing interruptions and demand increase
0.4% Lidocaine Hydrochloride and 5% Dextrose in 500mL Excel Plastic container P5941 (NDC 00264-9594-10) Product on allocation to contracted customers

Dear Customer Letter

Manufacturing interruptions and demand increase

Baxter Healthcare (New 10/25/2017)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Lidocaine Hydrochloride 0.4% and 5% Dextrose Injection USP (4mg/mL) in VIAFLEX container (1 gram/250 mL bag). Product code JB0972P (NDC 0338-9590-30) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Lidocaine HCl 0.4% and 5% Dextrose Injection USP in VIAFLEX Plus plastic container into the U.S. market to address drug shortages.

Dear Health Care Letter, Canada

Other
Lidocaine Hydrochloride 0.4% and 5% Dextrose Injection USP (4mg/mL) in VIAFLEX container (2 gram/500 mL bag) Product code JB0973 (NDC 0338-9586-24) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Lidocaine HCl 0.4% and 5% Dextrose Injection USP in VIAFLEX Plus plastic container into the U.S. market to address drug shortages.

Dear Health Care Letter, Canada

Other
Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/500 mL (4mg/mL) in VIAFLEX Plus container. Product code 2B0973 (NDC 0338-0409-03) On allocation Other
Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/250 mL (8mg/mL) in VIAFLEX Plus container. Product code 2B0962 (NDC 0338-0411-02) On allocation Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English